Search Results for "opioids"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for opioids. Results 121 to 130 of 180 total matches.

Ketorolac Tromethamine

   
The Medical Letter on Drugs and Therapeutics • Aug 24, 1990  (Issue 825)
less postoperative constipation and drowsiness than opioids. It does not have the depen- dence ...
Ketorolac (kee'; toe role ak) tromethamine (Toradol), manufactured by Syntex but also marketed by Roche, is the first parenteral nonsteroidal anti-inflammatory drug (NSAID) to become available for analgesic use in the USA. Parenteral indomethacin (Indocin I.V.) has been marketed here since 1985, but only for treatment of patent ductus arteriosus in newborn infants. Other parenteral NSAIDs are available in other parts of the world, but low potency, poor aqueous solubility, and substantial tissue irritation on injection have limited their usefulness. Ketorolac has been approved by the US ...
Med Lett Drugs Ther. 1990 Aug 24;32(825):79-80 |  Show IntroductionHide Introduction

Tests for Drugs of Abuse

   
The Medical Letter on Drugs and Therapeutics • Aug 19, 2002  (Issue 1137)
structurally dissimilar opioids such as oxycodone (Oxycontin, and others) or meperidine (Demerol, and others ...
Testing for drug use has become increasingly common, not only in health care, but also in drug rehabilitation, in the military, at the workplace, after accidents and in the criminal justice system. Performance-enhancing drugs such as anabolic steroids, growth hormone (Genotropin, and others) and erythropoietin (Procrit, Epogen) are not discussed here.
Med Lett Drugs Ther. 2002 Aug 19;44(1137):71-3 |  Show IntroductionHide Introduction

CYP3A and Drug Interactions

   
The Medical Letter on Drugs and Therapeutics • Jul 04, 2005  (Issue 1212)
), troleandomycin (TAO) Opioids: alfentanyl (Alfenta*), fentanyl (Sublimaze*), sufentanil (Sufenta*) Steroids ...
Serious adverse interactions between drugs continue to be reported. Many of these are due to inhibition or induction of cytochrome P450 (CYP) enzymes, particularly CYP3A4. CYP3A is thought to be involved in the metabolism of more than 50 percent of currently prescribed drugs.2 CYP3A4, which is more abundantly expressed than CYP3A5, accounts for most CYP3A activity in vivo.
Med Lett Drugs Ther. 2005 Jul 4;47(1212):54-5 |  Show IntroductionHide Introduction

Intranasal Diazepam (Valtoco) and Midazolam (Nayzilam) for Seizure Clusters

   
The Medical Letter on Drugs and Therapeutics • Apr 20, 2020  (Issue 1596)
inhibitors.6 Concurrent administration of benzodiazepines and opioids can cause profound sedation ...
The FDA has approved nasal spray formulations of the benzodiazepines diazepam (Valtoco — Neurelis) and midazolam (Nayzilam — UCB) for acute treatment of intermittent episodes of frequent seizure activity (seizure clusters). Diazepam rectal gel (Diastat, Diastat AcuDial, and generics) has been used for this indication for many years.
Med Lett Drugs Ther. 2020 Apr 20;62(1596):63-4 |  Show IntroductionHide Introduction

Gamma Hydroxy Butyrate Poisoning

   
The Medical Letter on Drugs and Therapeutics • Jan 25, 1991  (Issue 836)
neuroactive, increasing dopamine levels in the brain and acting on the endogenous opioid system (M Mamelak ...
Gamma hydroxy butyrate (GHB) sold in health food stores has recently caused outbreaks of gastrointestinal illness, central-nervous-system (CNS) depression, and seizures.
Med Lett Drugs Ther. 1991 Jan 25;33(836):8 |  Show IntroductionHide Introduction

In Brief: Palladone Withdrawn

   
The Medical Letter on Drugs and Therapeutics • Aug 01, 2005  (Issue 1214)
Oramorph opioids MS Contin Morphine Kadian Hydromorphone ...
The Medical Letter review of Palladone (hydromorphone HCl) extended-release capsules (March 14, 2005) warned that a lethal dose could be released if the new formulation was taken with alcohol. Because of that risk, the FDA asked the manufacturer (Purdue) to withdraw the drug from the market (FDA News. July 13, 2005; FDC Reports – “The Pink Sheet” July 18, 2005; 67:3).
Med Lett Drugs Ther. 2005 Aug 1;47(1214):61 |  Show IntroductionHide Introduction

Table: Some Drug Interactions with Drugs for IBD (online only)

   
The Medical Letter on Drugs and Therapeutics • Jul 10, 2023  (Issue 1680)
opioids) or noradrenergic drugs with ozanimod could result in hypertensive crisis and is not recommended ...
View the Table: Some Drug Interactions with Drugs for IBD
Med Lett Drugs Ther. 2023 Jul 10;65(1680):e114   doi:10.58347/tml.2023.1680c |  Show IntroductionHide Introduction

Gabapentin (Neurontin) for Chronic Pain

   
The Medical Letter on Drugs and Therapeutics • Apr 12, 2004  (Issue 1180)
not respond as well as other types of pain to standard doses of opioids. Anticonvulsants are often used ...
Gabapentin (Neurontin - Pfizer), which has been available in the US since 1994, is approved by the FDA only for treatment of partial epilepsy and postherpetic neuralgia, but is widely used off-label for a number of other indications, especially neuropathic pain syndromes. According to one report, among Medicaid recipients in Florida receiving gabapentin, 71% of prescriptions were for chronic pain and 8% for seizures and neuralgia ("The Pink Sheet" February 2, 2004; 66:30).
Med Lett Drugs Ther. 2004 Apr 12;46(1180):29-31 |  Show IntroductionHide Introduction

Uterine Artery Embolization for Fibroids

   
The Medical Letter on Drugs and Therapeutics • Apr 11, 2005  (Issue 1206)
and administration of parenteral opioids. UAE is generally not recommended for women who have not completed ...
Uterine artery embolization (UAE) is an increasingly used alternative to surgery for treatment of uterine fibroids.
Med Lett Drugs Ther. 2005 Apr 11;47(1206):31-2 |  Show IntroductionHide Introduction

Drugs for Anxiety Disorders

   
The Medical Letter on Drugs and Therapeutics • Aug 07, 2023  (Issue 1682)
depressants can result in additive CNS depression. Benzodiazepines are often used concurrently with opioids ...
Anxiety disorders (generalized anxiety disorder, panic disorder, social anxiety disorder, and various phobias) are the most common form of psychiatric illness. They can be treated effectively with cognitive behavioral therapy (CBT) and/or pharmacotherapy.
Med Lett Drugs Ther. 2023 Aug 7;65(1682):121-8   doi:10.58347/tml.2023.1682a |  Show IntroductionHide Introduction